GRAIL, Inc. Cost, Amortization
GRAIL, Inc. (GRAL) reported Cost, Amortization of $33.47 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSoldAmortization · last filed 2025-11-13
- GRAIL, Inc. cost, amortization for the quarter ending 2025-09-30 was $33.47M, a 0.00% change year-over-year.
- GRAIL, Inc. cost, amortization for the quarter ending 2025-06-30 was $33.47M, a 0.00% change year-over-year.
- GRAIL, Inc. cost, amortization for the quarter ending 2025-03-31 was $33.47M, a 0.00% change year-over-year.
- GRAIL, Inc. cost, amortization for the quarter ending 2024-12-31 was $33.47M.
- GRAIL, Inc. cost, amortization for fiscal 2024 was $133.89M, a 0.00% change from fiscal 2023.
- GRAIL, Inc. cost, amortization for fiscal 2023 was $133.89M, a 0.00% change from fiscal 2023.
- GRAIL, Inc. cost, amortization for fiscal 2023 was $133.89M.
| Period end | Cost, Amortization 3 month | Cost, Amortization 6 month | Cost, Amortization 9 month | Cost, Amortization 12 month |
|---|---|---|---|---|
| 2025-09-30 | $33.47M 10-Q · filed 2025-11-13 | $66.94M derived: sum of 2 quarters · filed 2025-11-13 | $100.42M 10-Q · filed 2025-11-13 | $133.89M derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | $33.47M 10-Q · filed 2025-08-13 | $66.94M 10-Q · filed 2025-08-13 | $100.42M derived: sum of 3 quarters · filed 2025-08-13 | $133.89M derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-03-31 | $33.47M 10-Q · filed 2025-05-14 | $66.94M derived: sum of 2 quarters · filed 2025-05-14 | $100.42M derived: sum of 3 quarters · filed 2025-11-13 | $133.89M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-12-31 | $33.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $66.94M derived: sum of 2 quarters · filed 2025-11-13 | $100.42M derived: sum of 3 quarters · filed 2025-11-13 | $133.89M 10-K · filed 2025-03-05 |
| 2024-09-30 | $33.47M 10-Q · filed 2025-11-13 | $66.94M derived: sum of 2 quarters · filed 2025-11-13 | $100.42M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $33.47M 10-Q · filed 2025-08-13 | $66.94M 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $33.47M 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | $133.89M 10-K · filed 2025-03-05 | |||
| 2023-10-01 | $33.47M 10-Q · filed 2024-11-13 | $66.94M derived: sum of 2 quarters · filed 2024-11-13 | $100.42M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $33.47M 10-Q · filed 2024-08-13 | $66.94M 10-Q · filed 2024-08-13 | ||
| 2023-01-01 | $133.89M 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |